Tags: Drug.
CJC-1295 is a tetrasubstituted 30-amino acid peptide hormone primarily functioning as a growth hormone releasing hormone (GHRH) analog. It was invented by ConjuChem a Canadian biotechnology company.One of the advantages of CJC-1295 over traditional GHRH or rHGH is its ability to bioconjugate with serum albumin thus increasing its half-life and therapeutic window. It accomplishes this by using protecting groups around the amino acids of GHRH typically susceptible to enzymatic degradation.